ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Spero Therapeutics (SPRO) Technical (Analysis) Reports Spero Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Spero Therapeutics (SPRO)

Technical Analysis Report for NASDAQ stock SPRO Spero Therapeutics. Dated: 26 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SPRO Spero Therapeutics then click here. or read Experts views on Spero Therapeutics or Forecast & share price targets of Spero Therapeutics

Spero Therapeutics Opened at 2.43 and Closed at: 2.36, which is -2.12% of previous session's close. It moved within a range of 2.34 and 2.52
The session was a Bearish session with an average volume of 338459, which is 44.1% of previous session's volumes.

    A Golden cross was found 9 days back on mid term averages

    A Golden cross was found 7 days back on long term averages

    Support for tomorrow is 2.26 and resistance for tomorrow is 2.44
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 2.29, 2.23 resistance for tomorrow's hourly charts is 2.47, 2.59

    10 Day SMA for Spero Therapeutics (SPRO) is 2.47 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Spero Therapeutics (SPRO) is 2.38 and the stock is trading below these levels. This is not a good sign for its mid term trend

    50 Day SMA for Spero Therapeutics (SPRO) is 2.36 and the stock is trading above these levels. This is a good sign for its mid to long term trend

    100 Day SMA is 2.37 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Spero Therapeutics is 2.34 and stock is trading above these levels. This is a good sign for its long term trend

    20 DMA of Spero Therapeutics is at 2.38 and 200 DMA is at 2.34, while 50 DMA and 100 DMA are at 2.36 and 2.37 respectively

    Spero Therapeutics (SPRO) moving average of 20 SMA is at 2.38 and 20 EMA is at 2.4

    Spero Therapeutics (SPRO) moving average of 50 SMA is at 2.36 and 50 EMA is at 2.37

    Spero Therapeutics (SPRO) moving average of 100 SMA is at 2.37 and 100 EMA is at 2.3

    Spero Therapeutics (SPRO) moving average of 200 SMA is at 2.34 and 200 EMA is at 2.05

    Spero Therapeutics has performed better than Xeris Pharmaceuticals in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Verrica Pharmaceuticals in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Rhythm Pharmaceuticals in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Quidel Corporation in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Ptc Therapeutics in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Marker Therapeutics in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Meiragtx Holdings in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Karyopharm Therapeutics in short term. Holding Spero Therapeutics could be a better choice for now!

    Kiniksa Pharmaceuticals has performed better than Spero Therapeutics in short term. You could have earned much better returns by investing in Kiniksa Pharmaceuticals, about 0.77% more returns!

    Spero Therapeutics has performed better than Inovio Pharmaceuticals in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Geron Corporation in short term. Holding Spero Therapeutics could be a better choice for now!

    Equillium Inc has performed better than Spero Therapeutics in short term. You could have earned much better returns by investing in Equillium Inc, about 11.6% more returns!

    Spero Therapeutics has performed better than Cue Biopharma in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Autolus Therapeutics in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Argenx Se in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Angiodynamics Inc in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics has performed better than Abeona Therapeutics in short term. Holding Spero Therapeutics could be a better choice for now!

    Spero Therapeutics Technical analysis of indicators

    Price action analysis of Spero Therapeutics (SPRO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.

    ADX buy sell signal for Spero Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a SELL signal for Spero Therapeutics in short term but the sell signal is initial and weak.

    Spero Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

    Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down

    CCI has generated a SELL signal for Spero Therapeutics in short term and SELL signal is strong!

    RSI is generating a BUY signal in short term but buying is losing momentum.

    MRSI is in positive zone. This is a BUY zone

    Although the stock is in the BUY zone, but buying might be slowing down

    Stock of Spero Therapeutics is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 2.47 and Spero Therapeutics SPRO stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Spero Therapeutics SPRO stock. Volume based technical analysis of Spero Therapeutics SPRO stock is negative.

    Spero Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock SPRO Spero Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And SPRO Experts View which covers a lot of information including buying and selling signals

    SPRO future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Spero Therapeutics or View Candle Stick Charts here

    Chart Spero Therapeutics (SPRO)  Technical (Analysis) Reports Spero Therapeutics [

    Videos related to: Spero Therapeutics (SPRO) Technical (Analysis) Reports Spero Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Spero Therapeutics (SPRO)  Technical (Analysis) Reports Spero Therapeutics [

     

    Back to top